z-logo
open-access-imgOpen Access
RADIOFREQUENCY FACILITATED MANUAL SEMI-ENDOSCOPIC DISCECTOMY UTILIZING THE DISC FX® SYSTEM IN THE TREATMENT OF DISC-PREDOMINATE LUMBAR SPINAL STENOSIS
Author(s) -
George J. Arcos
Publication year - 2018
Publication title -
pain management case reports
Language(s) - English
Resource type - Journals
ISSN - 2575-9841
DOI - 10.36076/pmcr.2018/2/173
Subject(s) - medicine , surgery , spinal stenosis , neurogenic claudication , lumbar spinal stenosis , lateral recess , investigational device exemption , stenosis , population , low back pain , spinal canal stenosis , lumbar , spinal canal , radiology , clinical trial , alternative medicine , environmental health , pathology , psychiatry , spinal cord
Background: Lumbar spinal stenosis (LSS)occurs with increasing prevalence in the elderlypopulation. The American Academy of OrthopedicSurgeons has estimated that by 2021,2.4 million adults in the United States (8-11% ofthe population) will be affected by this condition.Surgical options for LSS are being performedwith increased frequency, high cost, and substantialrisk of life-threatening complications.While nonsurgical treatment options for LSS areavailable, they are limited by patient selection(ligamentum flavum hypertrophy) or high ratesof reoperation (Interspinous process spacerdevices).This study is the first to suggest a minimallyinvasive treatment option for disc-predominatelumbar central canal stenosis.Objectives: To evaluate the clinical efficacy ofradiofrequency facilitated manual semi-endoscopicdiscectomy utilizing the Disc FX® systemin the treatment of disc-predominate lumbarspinal stenosis.Study Design: Single center, prospective, observationalstudy.Setting: Multi-specialty private practice clinic.The Medical Group of South Florida, Jupiter, FL.Methods: This study involved 6 patients withdisc-predominant lumbar central spinal stenosis.All patients were treated with the Disc FX®system. Radiographic evidence of central lumbarstenosis was confirmed by measurement of minimumAP canal diameter (mm) performed by 1board-certified neuroradiologist. Inclusion criteriaincluded absence of lumbar surgery, physicaltherapy within the previous 6 months, failure ofepidural steroid injections (3) within the previous8 months, spondylolisthesis limited to Grade I,disc height > 50%, presence of low back axialpain + leg pain exacerbated by walking, andrelieved with sitting or forward flexion, absenceof dermatomal radicular leg pain, radiographicevidence of disc displacement > 4 mm from discendplate. Zurich claudication (symptom severityand physical function scale was administered 1week preoperatively, and again 6 months postoperatively.There were no patients lost to follow up.Results: All patients in the study demonstratedmoderate-severe or severe central canal stenosis,with an average AP canal diameter of 6.63mm for all treated disc levels and 5.5 mm for themost severe levels. There was a mean improvementof 57% in a symptom severity scale and56% in the physical function scale at 6 months.This exceeds the improvement reported withinterspinous spacer devices.Limitations: Limitations include very smallsample size, observational design, non-randomization,absence of share controls, shortfollow-up period.Conclusion: For patients suffering from discpredominantlumbar spinal stenosis, The DiscFX® System provides an effective, low-costalternative to surgical intervention.Key words: Spinal, stenosis, claudication, disc,Disc FX®, operative, minimally invasive, Zürichclaudication score

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom